Search
shopping
Search
Menu

Goal and Learning Outcomes

The goal of this continuing education course is to update nurses’, advanced practice nurses’, and respiratory therapists’ clinical knowledge of lung cancer. After studying the information presented here, you will be able to:
  • Describe three risk factors for lung cancer.
  • Differentiate between two common types of lung cancer.
  • Describe three interventions used to treat lung cancer.
 

 
Beth Eaby-Sandy, MSN, CRNP, OCN, declared she is on the speaker’s bureau for Amgen, Celgene, Eisai and Merck; she has done consulting for AstraZeneca and Clovis. The planners reviewed the content and found it to be free of bias.
 

Course Authors

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.